Business ❯Pharmaceutical Industry ❯Drug Development

Clinical Trials

Market Impact Phase II Trials Competition Among Companies Eli Lilly Psychedelic Companies Cytokinetics AstraZeneca Gilead Sciences Product Recall Mounjaro Mounjaro Impact Pfizer's weight-loss pill candidates Vertex Pharmaceuticals Zepbound Innovative Treatments AIO-001 Hi1a Drug Trial Results Aduhelm Study Obesity Treatment Liver Disease Treatment HIV Prevention Drugs Market Competition

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

AstraZeneca Under Chinese Compliance Probe; Lung Cancer Drug Trial Results Disappoint

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

Gilead's Lenacapavir Shows 100% Efficacy in HIV Prevention Trial

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results

Gilead's Trodelvy Fails in Lung Cancer Trial, Stock Drops Over 10%

Spider Venom Molecule Shows Promise in Treating Heart Attacks and Strokes

GSK Acquires Aiolos Bio in $1.4 Billion Deal